Cefoxitin pharmacokinetics: relation to three different renal clearance studies in patients with various degrees of renal insufficiency. 1981

D Kampf, and R Schurig, and I Korsukewitz, and O Brückner

The pharmacokinetics of cefoxitin were examined in 4 healthy volunteers, 6 patients with normal renal function (inulin clearance, greater than 80 ml/min per 1.73 m2), and 35 patients with various degrees of renal insufficiency (inulin clearance, 80 to less than 5 ml/min per 1.73 m2). A single dose of 30 mg of cefoxitin per kg of body weight was injected intravenously over 3 min. Antibiotic concentrations in plasma were determined by the agar diffusion technique. The cefoxitin half-life increased progressively from 39 min in subjects with normal renal function to 23.5 h in oligoanuric patients. Correspondingly, total body clearance decreased from 340 to 13 ml/min per 1.73 m2. In addition to the study of cefoxitin kinetics, in 29 of the 41 patients, three different renal clearance tests were performed (inulin, p-aminohippurate, and creatinine clearances). Of these, p-aminohippurate clearance showed the best correlation with the elimination rate constant beta as well as total body clearance of cefoxitin; but with respect to beta, the differences between the p-aminohippurate and creatinine clearances were quantitatively negligible. Therefore, even in substances which are eliminated predominantly by active tubular secretion, creatinine clearance could be recommended for dosage adjustments.

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007674 Kidney Diseases Pathological processes of the KIDNEY or its component tissues. Disease, Kidney,Diseases, Kidney,Kidney Disease
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002440 Cefoxitin A semisynthetic cephamycin antibiotic resistant to beta-lactamase. Cefoxitin Sodium,MK-306,Mefoxin,Mefoxitin,Méfoxin,MK 306,MK306,Sodium, Cefoxitin
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
January 1979, Reviews of infectious diseases,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
May 1993, Clinical pharmacokinetics,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
January 1979, Reviews of infectious diseases,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
November 1976, The Journal of infectious diseases,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
March 2003, Journal of clinical pharmacology,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
June 1988, Antimicrobial agents and chemotherapy,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
March 1983, Antimicrobial agents and chemotherapy,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
April 1984, Antimicrobial agents and chemotherapy,
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
December 1979, Clinical science (London, England : 1979),
D Kampf, and R Schurig, and I Korsukewitz, and O Brückner
August 1991, British journal of clinical pharmacology,
Copied contents to your clipboard!